secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2025-01-24T23:59:59+00:00
Accession:  0001683168-25-000537
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis raises $1.1M convertible note and completes $10M Series A preferred stock sale
--------------------------------------------------------------------------------

- $1.1M convertible note to Yorkville with 8% interest, maturity Dec 31, 2025; conversion price with floor at $1.00.
- Series A preferred stock sale raises ~$10M from accredited investors at $1,000 per share.
- Preferred investors receive 13.91% non-voting equity in subsidiaries SNAP Biosciences and GEAR Therapeutics.
- Board member Christopher Calise participated in the Series A offering.
- Note includes amortization events triggering monthly payments of $250k principal plus 5% premium.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316825000537/0001683168-25-000537-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316825000537/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000537

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer